Navidea Biopharmaceuticals DPO Ratio 2011-2026 | NAVB

Annual DPO Ratio Navidea Biopharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
333 K	-	405 K	60.9 K	1.6 K	85.5 K	1.13 K	368	340	2.66 K	-	-

All numbers in USD currency

Maximum	Minimum	Average
405 K	340	98.9 K

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	133 K	385 K	-	-	-	-	-	-	1.29 M	297 K	170 K	-	520 K	426 K	11.4 K	-	1.02 K	1.1 K	184 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
1.29 M	1.02 K	311 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	405	$ 0.88	-1.69 %	$ 6.47 M	China
Aquestive Therapeutics AQST	395	$ 4.1	1.23 %	$ 438 M	USA
ACADIA Pharmaceuticals ACAD	75.2	$ 22.45	1.13 %	$ 3.72 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Cerus Corporation CERS	242	$ 2.03	5.73 %	$ 387 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Caladrius Biosciences CLBS	51.2	-	-16.75 %	$ 25.8 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Deciphera Pharmaceuticals DCPH	2.2 K	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Dynavax Technologies Corporation DVAX	52.8	-	-	$ 2.02 B	USA
Eiger BioPharmaceuticals EIGR	84.3 K	-	-9.21 %	$ 2.55 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA